| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
96,276 |
90,323 |
$2.92M |
| 96156 |
|
40,076 |
39,858 |
$2.72M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
37,262 |
35,772 |
$1.64M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
17,570 |
17,552 |
$809K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12,541 |
12,523 |
$709K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16,091 |
16,016 |
$629K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,672 |
7,680 |
$628K |
| G9920 |
Screening performed and negative |
22,181 |
22,114 |
$468K |
| 92551 |
|
41,805 |
41,668 |
$442K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,670 |
8,571 |
$373K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
11,798 |
11,609 |
$216K |
| 90686 |
|
24,355 |
24,307 |
$206K |
| 96151 |
|
9,058 |
9,029 |
$204K |
| 99215 |
Prolong outpt/office vis |
3,463 |
3,382 |
$201K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,733 |
5,549 |
$200K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,321 |
1,318 |
$167K |
| 87428 |
|
2,193 |
2,151 |
$112K |
| 97802 |
|
3,699 |
3,692 |
$98K |
| 99383 |
|
1,410 |
1,406 |
$96K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
10,698 |
10,503 |
$84K |
| 99381 |
|
1,146 |
1,135 |
$83K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,962 |
11,780 |
$78K |
| 99384 |
|
884 |
883 |
$74K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
2,691 |
2,621 |
$65K |
| 90670 |
|
6,664 |
6,616 |
$60K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,766 |
3,372 |
$60K |
| 85018 |
|
31,384 |
31,283 |
$56K |
| 99382 |
|
819 |
815 |
$49K |
| 90633 |
|
6,219 |
6,196 |
$49K |
| 90620 |
|
3,603 |
3,592 |
$47K |
| 90651 |
|
5,315 |
5,311 |
$44K |
| 90734 |
|
4,290 |
4,284 |
$42K |
| 96111 |
|
541 |
541 |
$37K |
| 83655 |
|
3,767 |
3,749 |
$36K |
| 90715 |
|
3,668 |
3,664 |
$33K |
| 90697 |
|
2,155 |
2,155 |
$31K |
| 90698 |
|
3,692 |
3,679 |
$31K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
507 |
506 |
$31K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,156 |
2,131 |
$29K |
| 96150 |
|
1,233 |
1,222 |
$28K |
| 90649 |
|
2,862 |
2,860 |
$27K |
| 90710 |
|
3,106 |
3,102 |
$26K |
| 90681 |
|
3,116 |
3,098 |
$26K |
| 99188 |
|
1,833 |
1,822 |
$26K |
| 90696 |
|
2,913 |
2,909 |
$24K |
| 90716 |
|
2,813 |
2,807 |
$24K |
| 90707 |
|
2,632 |
2,625 |
$22K |
| 90744 |
|
2,343 |
2,317 |
$21K |
| G9919 |
Screening performed and positive and provision of recommendations |
654 |
650 |
$18K |
| 96127 |
|
3,607 |
3,590 |
$17K |
| 69210 |
|
507 |
494 |
$16K |
| 90671 |
|
1,502 |
1,502 |
$14K |
| 90700 |
|
1,388 |
1,374 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,774 |
2,699 |
$12K |
| 99000 |
|
3,379 |
3,342 |
$12K |
| D1206 |
Topical application of fluoride varnish |
672 |
666 |
$12K |
| 90619 |
|
1,855 |
1,855 |
$12K |
| 17110 |
|
116 |
110 |
$12K |
| 90674 |
|
3,203 |
3,201 |
$11K |
| 91321 |
|
92 |
92 |
$10K |
| 90480 |
|
234 |
234 |
$9K |
| 90672 |
|
1,014 |
1,012 |
$9K |
| 90723 |
|
971 |
943 |
$9K |
| 99173 |
|
1,047 |
1,045 |
$8K |
| 90621 |
|
667 |
667 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
181 |
180 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
106 |
105 |
$8K |
| 90658 |
|
795 |
795 |
$7K |
| 81000 |
|
2,792 |
2,706 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
500 |
415 |
$7K |
| 91322 |
|
42 |
42 |
$6K |
| 99174 |
|
144 |
144 |
$5K |
| 86580 |
|
1,140 |
1,127 |
$5K |
| 90648 |
|
500 |
500 |
$4K |
| 69209 |
|
446 |
398 |
$4K |
| 94664 |
|
394 |
391 |
$4K |
| 0124A |
|
84 |
84 |
$3K |
| 0111A |
|
61 |
61 |
$2K |
| 85999 |
|
755 |
755 |
$2K |
| 90685 |
|
235 |
232 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
118 |
118 |
$2K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
72 |
47 |
$2K |
| 81025 |
|
747 |
738 |
$2K |
| 90647 |
|
228 |
228 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
22 |
22 |
$2K |
| 0072A |
|
39 |
39 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
328 |
324 |
$1K |
| 0112A |
|
36 |
36 |
$1K |
| 81002 |
|
470 |
452 |
$1K |
| 99406 |
|
91 |
90 |
$947.31 |
| 82465 |
|
195 |
195 |
$785.16 |
| 88720 |
|
169 |
135 |
$713.76 |
| 90713 |
|
79 |
79 |
$711.00 |
| 0003A |
|
14 |
14 |
$560.00 |
| 0071A |
|
14 |
14 |
$560.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
28 |
26 |
$528.75 |
| 94010 |
|
21 |
21 |
$516.60 |
| 90677 |
|
568 |
568 |
$513.00 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
12 |
12 |
$492.24 |
| 0154A |
|
12 |
12 |
$480.00 |
| 94150 |
|
35 |
34 |
$194.95 |
| 82947 |
|
42 |
40 |
$144.26 |
| 94760 |
|
20 |
20 |
$111.80 |
| 99001 |
|
390 |
368 |
$41.25 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
147 |
110 |
$32.34 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
140 |
109 |
$26.54 |
| 90661 |
|
1,282 |
1,282 |
$0.00 |
| 90660 |
|
13 |
13 |
$0.00 |